• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

隐静脉移植血管支架置入术后无复流现象的那不勒斯预后评分的预测价值。

Predictive value of the Naples prognostic score for no-reflow phenomenon after saphenous vein graft stenting.

作者信息

Yılmaz Cemalettin, Karaduman Ahmet, Tiryaki Muhammet Mücahit, Güvendi Şengör Büşra, Unkun Tuba, Kültürsay Barkın, Zehir Regayip

机构信息

Department of Cardiology, Malazgirt State Hospital, Malazgirt, Mus, Turkey.

Department of Cardiology, Kartal Kosuyolu Research and Education Hospital, Kartal, Istanbul, Turkey.

出版信息

Biomark Med. 2025 Jan;19(1):13-22. doi: 10.1080/17520363.2024.2443383. Epub 2024 Dec 22.

DOI:10.1080/17520363.2024.2443383
PMID:39711087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11731040/
Abstract

BACKGROUND

No-reflow is a critical adverse event associated with percutaneous coronary intervention (PCI), particularly during saphenous vein graft (SVG) procedures. The Naples Prognostic Score (NPS) reflects inflammatory status, but its relationship with no-reflow remains unclear. Therefore, we aimed to evaluate the relationship between NPS and no-reflow occurrence following SVG PCI.

METHODS

We retrospectively analyzed 286 patients who underwent SVG PCI from January 2020 to January 2024, with a median age of 65 years and 85.7% male. Participants were categorized into low NPS (0-2, 48.6%) and high NPS (3-4, 51.4%) groups. Two nested models were developed by adding NPS (continuous and categorical, respectively) to the base model.

RESULTS

Higher no-reflow rates were noted in the high-NPS group (48.5% vs. 9.5%,  < 0.05). Multivariable regression revealed that a higher NPS significantly increased no-reflow risk, with odds ratios of 5.966 (95% CI: 3.066-11.611) for continuous NPS and 10.110 (95% CI: 3.194-32.002) for categorical NPS. Adding NPS to the base model significantly improved predictive performance (likelihood-ratio test  < 0.001). Model 1 demonstrated the best performance (X : 84.857, R : 0.468) and discriminative ability (AUC: 0.888).

CONCLUSION

Our findings suggest that NPS is a strong predictor of no-reflow following SVG PCI.

摘要

背景

无复流是经皮冠状动脉介入治疗(PCI)相关的严重不良事件,尤其是在大隐静脉桥血管(SVG)手术过程中。那不勒斯预后评分(NPS)反映炎症状态,但其与无复流的关系仍不清楚。因此,我们旨在评估NPS与SVG PCI术后无复流发生之间的关系。

方法

我们回顾性分析了2020年1月至2024年1月期间接受SVG PCI的286例患者,中位年龄为65岁,男性占85.7%。参与者被分为低NPS组(0 - 2分,48.6%)和高NPS组(3 - 4分,51.4%)。通过分别将NPS(连续变量和分类变量)添加到基础模型中,建立了两个嵌套模型。

结果

高NPS组的无复流率更高(48.5%对9.5%,<0.05)。多变量回归显示,较高的NPS显著增加无复流风险,连续NPS的优势比为5.966(95%置信区间:3.066 - 11.611),分类NPS的优势比为10.110(95%置信区间:3.194 - 32.002)。将NPS添加到基础模型中显著提高了预测性能(似然比检验<0.001)。模型1表现出最佳性能(X²:84.857,R²:0.468)和判别能力(AUC:0.888)。

结论

我们的研究结果表明,NPS是SVG PCI术后无复流的有力预测指标。

相似文献

1
Predictive value of the Naples prognostic score for no-reflow phenomenon after saphenous vein graft stenting.隐静脉移植血管支架置入术后无复流现象的那不勒斯预后评分的预测价值。
Biomark Med. 2025 Jan;19(1):13-22. doi: 10.1080/17520363.2024.2443383. Epub 2024 Dec 22.
2
Relationship Between the Naples Prognostic Score and Saphenous Vein Graft Disease after Coronary Artery Bypass Grafting Surgery.冠状动脉旁路移植术后那不勒斯预后评分与隐静脉移植物疾病的关系
Arq Bras Cardiol. 2025 Apr;122(5):e20240519. doi: 10.36660/abc.20240519.
3
PCSK-9 Inhibitors Can Significantly Improve the Coronary Slow Flow Caused by Elevated Lipoprotein (a) in ST-Elevation Myocardial Infarction Patients With Chronic Kidney Disease.前蛋白转化酶枯草溶菌素9(PCSK-9)抑制剂可显著改善慢性肾脏病合并ST段抬高型心肌梗死患者因脂蛋白(a)升高所致的冠状动脉慢血流现象。
Catheter Cardiovasc Interv. 2025 Jul;106(1):396-407. doi: 10.1002/ccd.31543. Epub 2025 Apr 25.
4
Comparison of Drug-Eluting Stents With Bare-Metal Stents for PCI of Saphenous Vein Graft Lesions: Systematic Review and Meta-Analysis.药物洗脱支架与裸金属支架用于隐静脉桥病变经皮冠状动脉介入治疗的比较:系统评价和荟萃分析。
J Invasive Cardiol. 2016 Dec;28(12):E139-E169. Epub 2016 Nov 15.
5
Preoperative coronary interventions for preventing acute myocardial infarction in the perioperative period of major open vascular or endovascular surgery.术前冠状动脉介入治疗预防大型开放性血管或血管内手术后围手术期急性心肌梗死。
Cochrane Database Syst Rev. 2024 Jul 3;7(7):CD014920. doi: 10.1002/14651858.CD014920.pub2.
6
Effect of dapagliflozin on the no-reflow phenomenon in patients with acute myocardial infarction and type II diabetes mellitus.达格列净对急性心肌梗死合并2型糖尿病患者无复流现象的影响。
Acta Cardiol. 2025 Jun;80(4):394-402. doi: 10.1080/00015385.2025.2500892. Epub 2025 May 14.
7
The impact of the Naples prognostic score in long-term outcomes after percutaneous coronary intervention for chronic total occlusions.那不勒斯预后评分对慢性完全闭塞病变经皮冠状动脉介入治疗后长期预后的影响。
Coron Artery Dis. 2025 Feb 7. doi: 10.1097/MCA.0000000000001512.
8
Graft type for femoro-popliteal bypass surgery.股腘动脉搭桥手术的移植物类型。
Cochrane Database Syst Rev. 2018 Feb 11;2(2):CD001487. doi: 10.1002/14651858.CD001487.pub3.
9
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
10
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.

本文引用的文献

1
The effect of the systemic immune-inflammatory index on the no-reflow phenomenon in patients undergoing saphenous vein intervention.全身免疫炎症指数对接受大隐静脉介入治疗患者无复流现象的影响。
Postepy Kardiol Interwencyjnej. 2024 Jun;20(2):148-156. doi: 10.5114/aic.2024.140259. Epub 2024 Jun 4.
2
Postdilatation after stent deployment during primary percutaneous coronary intervention: a systematic review and meta-analysis.支架置入后行球囊后扩张治疗在直接经皮冠状动脉介入治疗中的应用:系统评价和荟萃分析。
Postgrad Med J. 2024 Oct 18;100(1189):827-835. doi: 10.1093/postmj/qgae073.
3
The impact of the Naples Prognostic Score on the short- and long-term prognosis of patients undergoing transcatheter aortic valve implantation.
那不勒斯预后评分对行经导管主动脉瓣植入术患者短期和长期预后的影响。
J Cardiovasc Med (Hagerstown). 2024 Jul 1;25(7):519-528. doi: 10.2459/JCM.0000000000001637. Epub 2024 May 20.
4
Naples Prognostic Score as a Novel Biomarker of Prognosis in Patients With ST-Segment Elevation Myocardial Infarction.那不勒斯预后评分作为ST段抬高型心肌梗死患者预后的新型生物标志物
Angiology. 2024 Apr 28:33197241251888. doi: 10.1177/00033197241251888.
5
Evaluation of Naples prognostic score to predict long-term mortality in patients with pulmonary embolism.评估那不勒斯预后评分对预测肺栓塞患者长期死亡率的价值。
Biomark Med. 2024;18(6):253-263. doi: 10.2217/bmm-2023-0741. Epub 2024 Mar 15.
6
Clinical implication of the Naples prognostic score on transcatheter aortic valve replacement in patients with severe aortic stenosis.那不勒斯预后评分对严重主动脉瓣狭窄患者经导管主动脉瓣置换术的临床意义。
Catheter Cardiovasc Interv. 2024 Jan;103(1):219-225. doi: 10.1002/ccd.30929. Epub 2023 Dec 22.
7
Saphenous Vein Graft Failure: Current Challenges and a Review of the Contemporary Percutaneous Options for Management.大隐静脉移植血管失败:当前挑战及当代经皮治疗选择综述
J Clin Med. 2023 Nov 15;12(22):7118. doi: 10.3390/jcm12227118.
8
The prognostic importance of the Naples prognostic score for in-hospital mortality in patients with ST-segment elevation myocardial infarction.那不勒斯预后评分对ST段抬高型心肌梗死患者院内死亡率的预后重要性。
Coron Artery Dis. 2024 Jan 1;35(1):31-37. doi: 10.1097/MCA.0000000000001285. Epub 2023 Nov 2.
9
A novel prognostic prediction indicator in patients with acute pulmonary embolism: Naples prognostic score.急性肺栓塞患者的一种新型预后预测指标:那不勒斯预后评分。
Thromb J. 2023 Nov 6;21(1):114. doi: 10.1186/s12959-023-00554-8.
10
2023 ESC Guidelines for the management of acute coronary syndromes.2023年欧洲心脏病学会急性冠状动脉综合征管理指南
Eur Heart J Acute Cardiovasc Care. 2024 Feb 9;13(1):55-161. doi: 10.1093/ehjacc/zuad107.